AI Analysis of Video Can ID Neurologic Changes in the NICU

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 19, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 19, 2024 -- Deep learning with pose artificial intelligence (AI) may offer a scalable, minimally invasive method for neuro-telemetry in the neonatal intensive care unit (NICU), according to a study published online Nov. 11 in eClinicalMedicine.

Alec Gleason, from the Albert Einstein College of Medicine in New York City, and colleagues assessed whether an AI-based computer vision method to track infant movement could predict neurologic changes in the NICU. The analysis included video data linked to electroencephalograms (video-EEG; 282,301 video minutes) from 115 infants with corrected age <1 year at four urban NICUs from Feb. 1, 2021, to Dec. 31, 2022.

The researchers found that infant pose was accurately predicted in cross-validation, held-out frames, and held-out infants with respective receiver operating characteristic area under the curves (ROC-AUCs) of 0.94, 0.83, and 0.89. After accounting for age, which was associated with median movement increases, median movement was lower with sedative medications and in infants with cerebral dysfunction. Sedation prediction had high performance on cross-validation, held-out intervals, and held-out infants (ROC-AUCs, 0.90, 0.91, and 0.87, respectively). Prediction of cerebral dysfunction also had high performance (ROC-AUCs, 0.91, 0.90, and 0.76, respectively).

"We envision a future system where cameras continuously monitor infants in the NICU, with AI providing a neuro-telemetry strip similar to heart rate or respiratory monitoring, with alert for changes in sedation levels or cerebral dysfunction," senior author Felix Richter, M.D., Ph.D., from the Icahn School of Medicine at Mount Sinai in New York City, said in a statement. "Clinicians could review videos and AI-generated insights when needed, offering an intuitive and easily interpretable tool for bedside care."

Several authors are named inventors of Pose AI to monitor neonatal mental status and have disclosed filing a provisional patent application.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-20 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords